|
시장보고서
상품코드
2058249
조루 치료 시장 : 약제 종류별, 투여 경로별, 제형별, 유통 채널별, 지역별Premature Ejaculation Treatment Market, By Drug Type, By Route of Administration, By Dosage Form, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
조루 치료 시장은 2026년에 32억 달러로 추정되며, 2033년까지 57억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 8.9%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 32억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 8.90% | 2033년 시장 규모 예측: | 57억 달러 |
조루는 급속 사정, 조기 사정 또는 조기 사출이라고도 합니다. 이는 성교 중에 정액이 너무 빨리 사정되어 버리는 장애입니다. 조루는 매우 흔한 문제이지만, 그 정확한 원인은 밝혀지지 않았습니다. 그러나 그 원인으로는 조기 성적 경험, 성적 학대, 신체 이미지 저하, 우울증, 불안, 호르몬 수치 이상, 유전적 요인, 전립선이나 요도의 염증 및 감염, 그리고 조루에 대한 불안 등이 꼽힙니다.
시장 역학
조루 치료용 신제품 출시가 증가함에 따라, 전 세계 조루 치료 시장의 성장이 가속화될 것으로 예상됩니다. 예를 들어, 2016년에는 홍콩에 본사를 둔 투자 그룹인 Regent Pacific Group Limited가 영국에서 자사 제품인 'Fortacin'을 출시했습니다. 포르타신은 리도카인과 프릴로카인이라는 두 가지 국소 마취제를 저용량으로 배합한 외용 스프레이로, 조루 치료제로 사용됩니다. 또한, 불건전한 생활 습관이나 우울증, 호르몬 불균형 등 다양한 요인으로 인한 조루 유병률의 증가가 조루 치료제 수요를 끌어올릴 것으로 예상됩니다. 예를 들어, 2016년 국립생물의약품정보센터가 발표한 자료에 따르면, 중국 남성의 약 25.8%가 조루로 고통받고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 조루 치료 시장의 주요 기업 개요을 작성했습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 및 전략, 그리고 향후 계획입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 '세계 조루 치료 시장 보고서'는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 조루 치료 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 조루 치료 시장 : 약물 유형별, 2021-2033년
제5장 세계의 조루 치료 시장 : 투여 경로별, 2021-2033년
제6장 세계의 조루 치료 시장 : 제형별, 2021-2033년
제7장 세계의 조루 치료 시장 : 유통 채널별, 2021-2033년
제8장 세계의 조루 치료 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSM 26.06.19Premature Ejaculation Treatment Market is estimated to be valued at USD 3.2 Bn in 2026 and is expected to reach USD 5.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.2 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.90% | 2033 Value Projection: | USD 5.7 Bn |
Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.
Market Dynamics
Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global premature ejaculation treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
- Key companies covered as a part of this study include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics
- The global premature ejaculation treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the premature ejaculation treatment market
Market Segmentation
- By Drug Type (Revenue, USD Bn, 2021-2033)
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Dapoxetine
- Others
- Phosphodiesterase Type 5 (PDE5) Inhibitors
- Zertane
- Others
- Topical Anesthetics
- Others
- By Route of Administration (Revenue, USD Bn, 2021-2033)
- Oral
- Topical
- By Dosage Form (Revenue, USD Bn, 2021-2033)
- Pills
- Spray
- Others
- By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospitals
- Online Pharmacies
- Retail Pharmacies
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Regent Pacific Group Limited
- Menarini Group
- Furiex Pharmaceuticals, Inc.
- Absorption Pharmaceuticals, LLC
- Ampio Pharmaceuticals, Inc.
- Aytu BioScience,
- NeuroHealing Pharmaceuticals Inc.
- Dong-A Pharmaceutical Co., Ltd.
Table of Contents
1. Research Objective and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- PEST Analysis
- Pipeline Analysis
- Product Approval
- Product Launch
- Collaboration-Acquisition
- Porter's Five Forces Analysis
4. Global Premature Ejaculation Treatment Market, By Drug Type, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Dapoxetine
- Others
- Phosphodiesterase Type 5 (PDE5) Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Zertane
- Others
- Topical Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Premature Ejaculation Treatment Market, By Route of Administration, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Premature Ejaculation Treatment Market, By Dosage Form, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Premature Ejaculation Treatment Market, By Distribution Channel, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Premature Ejaculation Treatment Market, By Region, 2021 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- North America
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
- GCC
- Israel
- Rest of Middle East
9. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Regent Pacific Group Limited
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Menarini Group
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Furiex Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Absorption Pharmaceuticals, LLC
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ampio Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aytu BioScience
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NeuroHealing Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dong-A Pharmaceutical Co., Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regent Pacific Group Limited
10. Section
- References
- Research Methodology
- About us and Sales Contact
